Evidence map›Paper›PMID 33911168›Full record

ArticleScientific reports2021

Selective deletion of SHIP-1 in hematopoietic cells in mice leads to severe lung inflammation involving ILC2 cells.

Xujun Ye, Fengrui Zhang, Li Zhou, Yadong Wei, Li Zhang, Lihui Wang, Haiying Tang, Zi Chen, William G Kerr, Tao Zheng and 1 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Xujun YeSection of Allergy and Clinical Immunology, Yale University School of Medicine, 333 Cedar Street, TAC S469C, New Haven, CT, 06510, USA.
Fengrui ZhangSection of Allergy and Clinical Immunology, Yale University School of Medicine, 333 Cedar Street, TAC S469C, New Haven, CT, 06510, USA.
Li ZhouDepartment of Internal Medicine, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China.
Yadong WeiSection of Allergy and Clinical Immunology, Yale University School of Medicine, 333 Cedar Street, TAC S469C, New Haven, CT, 06510, USA.
Li ZhangSection of Allergy and Clinical Immunology, Yale University School of Medicine, 333 Cedar Street, TAC S469C, New Haven, CT, 06510, USA.
Lihui WangSection of Allergy and Clinical Immunology, Yale University School of Medicine, 333 Cedar Street, TAC S469C, New Haven, CT, 06510, USA.
Haiying TangSection of Allergy and Clinical Immunology, Yale University School of Medicine, 333 Cedar Street, TAC S469C, New Haven, CT, 06510, USA.
Zi ChenSection of Allergy and Clinical Immunology, Yale University School of Medicine, 333 Cedar Street, TAC S469C, New Haven, CT, 06510, USA.
William G KerrDepartment of Microbiology and Immunology, SUNY Upstate Medical University, Syracuse, NY, 31210, USA.
Tao ZhengSection of Allergy and Clinical Immunology, Yale University School of Medicine, 333 Cedar Street, TAC S469C, New Haven, CT, 06510, USA.
Zhou ZhuSection of Allergy and Clinical Immunology, Yale University School of Medicine, 333 Cedar Street, TAC S469C, New Haven, CT, 06510, USA. zhou_zhu@brown.edu.
Yale University · USZhongnan Hospital of Wuhan University · CNBrown University · USSUNY Upstate Medical University · USWuhan University · CN

Funding

Translating SHIP1 Genetics to Generate a Novel Alzheimers Pharmacologic AgentRF1AG059717 · NIA · UNIVERSITY OF KENTUCKY · PI ESTUS, STEVEN, HUMPHREY, MARY BETH · 2018 to 2019
$3.9M
NIA NIH HHS RF1 AG059717NIH HHS P01HL10711
6 · The paper itself

Abstract

Src homology 2 domain-containing inositol 5-phosphatase 1 (SHIP-1) regulates the intracellular levels of phosphotidylinositol-3, 4, 5-trisphosphate, a phosphoinositide 3-kinase (PI3K) product. Emerging evidence suggests that the PI3K pathway is involved in allergic inflammation in the lung. Germline or induced whole-body deletion of SHIP-1 in mice led to spontaneous type 2-dominated pulmonary inflammation, demonstrating that SHIP-1 is essential for lung homeostasis. However, the mechanisms by which SHIP-1 regulates lung inflammation and the responsible cell types are still unclear. Deletion of SHIP-1 selectively in B cells, T cells, dendritic cells (DC) or macrophages did not lead to spontaneous allergic inflammation in mice, suggesting that innate immune cells, particularly group 2 innate lymphoid cells (ILC2 cells) may play an important role in this process. We tested this idea using mice with deletion of SHIP-1 in the hematopoietic cell lineage and examined the changes in ILC2 cells. Conditional deletion of SHIP-1 in hematopoietic cells in Tek-Cre/SHIP-1 mice resulted in spontaneous pulmonary inflammation with features of type 2 immune responses and airway remodeling like those seen in mice with global deletion of SHIP-1. Furthermore, when compared to wild-type control mice, Tek-Cre/SHIP-1 mice displayed a significant increase in the number of IL-5/IL-13 producing ILC2 cells in the lung at baseline and after stimulation by allergen Papain. These findings provide some hints that PI3K signaling may play a role in ILC2 cell development at baseline and in response to allergen stimulation. SHIP-1 is required for maintaining lung homeostasis potentially by restraining ILC2 cells and type 2 inflammation.

Indexed as

AnimalsFibrosisHematopoietic Stem CellsImmunity, InnateLymphocytesMiceMice, Inbred C57BLMice, KnockoutPapainPhosphatidylinositol-3,4,5-Trisphosphate 5-PhosphatasesPneumoniaInpp5d protein, mousePapainPhosphatidylinositol-3,4,5-Trisphosphate 5-Phosphatases

Identifiers

PMID33911168
PMCPMC8080607
OpenAlexW3158051206

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.